A new survey conducted in Germany showed that, in addition to easing symptoms and improving quality of life, Trikafta…
Articles by Patricia Inácio, PhD
Persistent Pseudomonas aeruginosa infection in people with cystic fibrosis (CF) who have received treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) seems…
Almost 30% of cystic fibrosis (CF) patients who had a lung transplant in the U.S. were prescribed Trikafta…
The Cystic Fibrosis Foundation will invest up to $2.3 million for a company to develop a breath test designed to…
Treatment with Trikafta may help ease severe symptoms of anxiety and depression in children with cystic fibrosis (CF),…
A next-generation vest to help clear airway mucus in adults and children with cystic fibrosis (CF) or other lung…
About half of cystic fibrosis (CF) patients had used, were using, or were interested in using cannabidiol (CBD), the…
The Rare Disease Cures Accelerator-Data and Analytics Platform — dubbed RDCA–DAP — has received new datasets that promise to…
A 3-year-old boy who carries a new combination of two mutations in the CFTR gene, but with no clinical signs…
A new small molecule, called VOMG, showed good antimicrobial activity against Mycobacterium abscessus, a bacterium that can cause serious infections…